Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion type Assertion NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_head.
- NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion description "[We found that patients with DLBCL with the worst prognosis, according to the outcome predictor score, had decreased expression of catalase, glutathione peroxidase, manganese superoxide dismutase, and VDUP1, a protein that inhibits thioredoxin activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_provenance.
- NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion evidence source_evidence_curated NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_provenance.
- NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion SIO_000772 16081686 NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_provenance.
- NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion wasDerivedFrom ctd_human-20130708 NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_provenance.
- NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_assertion wasGeneratedBy ECO_0000218 NP10682.RAz1lHlRNufWoTn2chGLfUlSSHMCyrVZd_0tTKYXEU9PY130_provenance.